BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30892704)

  • 1. Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients.
    Lichvar A; Tremblay S; Naik D; Lipscomb J; King E; Vinks AA; Christians U; Alloway RR
    Pharmacotherapy; 2019 May; 39(5):564-575. PubMed ID: 30892704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.
    Naicker D; Reed PW; Ronaldson J; Kara T; Wong W; Prestidge C
    Pediatr Nephrol; 2017 Nov; 32(11):2125-2131. PubMed ID: 28660366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients.
    Heavner MS; Tichy EM; Yazdi M; Formica RN; Kulkarni S; Emre S
    Am J Health Syst Pharm; 2013 Sep; 70(17):1507-12. PubMed ID: 23943182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus.
    Riva N; Cáceres Guido P; Licciardone N; Imventarza O; Monteverde M; Staciuk R; Charroqui A; Schaiquevich P
    Farm Hosp; 2017 Mar; 41(2):150-168. PubMed ID: 28236795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic tacrolimus in solid organ transplantation.
    Taube D; Jones G; O'Beirne J; Wennberg L; Connor A; Rasmussen A; Backman L
    Clin Transplant; 2014 May; 28(5):623-32. PubMed ID: 24750309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of conversion from Advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study.
    Melo MJ; Gonçalves J; Guerra JO; Santana A; Nascimento C
    Transplant Proc; 2015 May; 47(4):911-3. PubMed ID: 26036484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
    Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
    Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients.
    Duong SQ; Lal AK; Joshi R; Feingold B; Venkataramanan R
    Pediatr Transplant; 2015 Dec; 19(8):911-7. PubMed ID: 26497983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients.
    Choi HJ; Kim DG; Kwak BJ; Han JH; Hong TH; You YK
    Drug Des Devel Ther; 2018; 12():295-301. PubMed ID: 29483770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial.
    Arns W; Huppertz A; Rath T; Ziefle S; Rump LC; Hansen A; Budde K; Lehner LJ; Shipkova M; Baeumer D; Kroeger I; Sieder C; Klein T; Schenker P
    Transplantation; 2017 Nov; 101(11):2780-2788. PubMed ID: 28658202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed.
    Robertsen I; Åsberg A; Ingerø AO; Vethe NT; Bremer S; Bergan S; Midtvedt K
    Transplantation; 2015 Mar; 99(3):528-32. PubMed ID: 25148382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STABIL-study: The Course of Therapy, Safety and Pharmacokinetic Parameters of Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal Transplant Recipients - an Observational Study in Germany.
    Lehner LJ; Kalb K; Weigand K; Pein U; Schenker P; Seeger W; Roehle R; Dienes K; Halleck F; Budde K
    Curr Rev Clin Exp Pharmacol; 2021; 16(4):357-368. PubMed ID: 33588739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic immunosuppressants.
    Medeiros M; Lumini J; Stern N; Castañeda-Hernández G; Filler G
    Pediatr Nephrol; 2018 Jul; 33(7):1123-1131. PubMed ID: 28733752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
    Kim SH; Lee SD; Kim YK; Park SJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring.
    Melilli E; Crespo E; Sandoval D; Manonelles A; Sala N; Mast R; Padulles A; Grinyo JM; Bestard O; Cruzado JM
    Transpl Int; 2015 Nov; 28(11):1283-90. PubMed ID: 26088437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converting immunosuppression from an oral suspension to a granule formulation of tacrolimus in pediatric renal transplant recipients.
    Malakasioti G; Booth C; Marks SD
    Pediatr Transplant; 2018 Aug; 22(5):e13214. PubMed ID: 29767471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.